Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export corporate actions as CSV.

DR LALCHANDANI LABS LIMITED

Healthcare · Healthcare Services

BSE: 541299
₹6.89
▼ -0.36 (-4.97%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
28/100
Weak
Valuation
—/100
Data unavailable
Momentum
44/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-68.6
Free Cash Flow
₹-1 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
3.79
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 3 met
  • No Quality score is Strong (70 or more)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 1 met
  • No 1-year return beats the industry median

Value and momentum

0 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-5.0%
Low 6.8900 · High 6.8900
1W return
-7.1%
Low 6.8900 · High 7.2500
1M return
-11.6%
Low 6.8900 · High 8.6000
52W return
-71.4%
Low 5.9700 · High 8.6000
Lifetime High ₹49.6500 (Dec. 6, 2021)
Lifetime Low ₹6.2800 (Aug. 12, 2026)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
7.3
10D
7.5
20D
8.3
50D
12.1
100D
16.1
200D
22.2

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
80.7%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

6.89
Pivot
First resistance6.89
Second resistance6.89
Third resistance6.89
First support6.89
Second support6.89
Third support6.89
Day RSI31.0
Day MFI28.2
Day MACD-1.47
Day MACD signal-1.89

Beta

1M—
3M-0.64
1Y-0.64
3Y-0.40

Price change analysis

↓ -11.6%
Over 1 Month
LowHigh
6.898.60
↓ -71.4%
Over 3 Months
LowHigh
5.978.60
↓ -71.4%
Over 6 Months
LowHigh
5.978.60
↓ -71.4%
Over 1 Year
LowHigh
5.978.60
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Ranks #None of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Mar 2026
  • Promoter32.90%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings increased from 31.15% to 32.90% in Mar 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
14 Aug 2026 SANATH KULALU Bulk Sell 88,000 6.0000 BSE
14 Aug 2026 RAJENDRA KUMAR JAIN HUF Bulk Buy 104,000 6.0300 BSE
13 Aug 2026 SUHITH PUNDALIKA BANGERA Bulk Sell 84,000 5.9900 BSE
11 Aug 2026 ANURAAG GAMBHIR Bulk Buy 32,000 6.8000 BSE
11 Aug 2026 ANURAAG GAMBHIR Bulk Sell 48,000 6.4900 BSE
11 Aug 2026 SUVOJIT SARKAR Bulk Sell 52,000 6.6400 BSE
11 Aug 2026 SUVOJIT SARKAR Bulk Buy 52,000 6.4800 BSE
11 Aug 2026 PANNA LAL AND SONS HUF Bulk Buy 52,000 6.4800 BSE
11 Aug 2026 REETHA VIKRAM Bulk Sell 76,000 6.4800 BSE
23 Jun 2026 PAVANA . Bulk Sell 72,000 6.8600 BSE

All bulk and block deals →

Corporate Announcements

All 1 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 Insider Trading / SAST Dr Lalchandani Labs Ltd - 541299 - Closure of Trading Window

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • Down 71.4% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about DR LALCHANDANI LABS LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.